FC

Franklin Covey is a high-quality but cyclically wounded business. Its subscription All Access Pass model still throws off a 76.2% gross margin, and despite a brutal fiscal year it converted revenue into $29.0M of operating cash flow — nearly 10x its $3.07M of GAAP net income and ~11% of the $265M market cap. Management pays no dividend and instead retired stock aggressively ($26.4M of buybacks in FY2025, shares down 7.8% YoY), which puts a real floor under per-share value. On that cash-flow lens the stock is not expensive; the headline 90.8x P/E is an artifact of a depressed $0.24 EPS, not a rich multiple on normal earnings (FY2024 net income was $23.4M).

The problem is that the depression is real and worsening, not a one-off. Revenue fell 7.0% to $267M — below FY2022 levels — and operating income collapsed 82.7% while net income fell 86.9%. Crucially, this wasn't just weak demand: SG&A rose to 68.4% of revenue (from 61.3%) because the company added sales headcount for a new North America go-to-market strategy and sales-force reorg whose payoff has not yet arrived. So the company spent more to earn less. The MD&A pins the North America shortfall on 'canceled or postponed government contracting' and the federal shutdown, and flags international deterioration (Japan -23%, China -21%, UK -15%) — and it explicitly warns that resolution of these tariff/macro/government-spending headwinds 'is not within our control.' Today's 12.8% drop signals the latest quarter did nothing to reverse that.